More than 1,000,000 percutaneous coronary intervention (PCI) procedures are performed in the U.S. every year and many more are performed annually worldwide.1 Even though hemostasis at the vascular access site has conventionally been achieved by manual compression followed by a period of recumbency, new devices have significantly increased the methods available to achieve hemostasis at the entry site.2 A number of complications are associated with percutaneous femoral access, including hemorrhage, thrombosis, embolization, and infection.3 Moreover, vascular complications occur in up to 7% of patients after PCI, including the development of arteriovenous fistulas, pseudoaneurysms, or large hematomas,4 and can require surgical repair and/or blood transfusions
Read the rest here:
QuikClot® Interventional™ Hemostatic Bandage (QCI): A Novel Hemostatic Agent for Vascular Access